Multi-level Influences of Alcohol Based Quality and Outcome Measures

酒精质量的多层次影响和结果测量

基本信息

  • 批准号:
    10704144
  • 负责人:
  • 金额:
    $ 23.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-13 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Unhealthy use of alcohol remains a critical problem with high-risk drinking increasing by almost 30% between 2001-2002 and 2012-2013. Excessive alcohol use is the third leading cause of preventable death, and is linked to chronic medical conditions, lost productivity and direct cost to health systems. Evidence-based practices are available to prevent and treat unhealthy alcohol use and its detrimental consequences. To facilitate uptake of these practices, health systems use quality measures to identify aspects of care being done well and monitor areas for improvement. The National Quality Forum has endorsed several care quality measures for unhealthy alcohol use, which have been adopted for routine decision-making by health systems. These include indicators for initiation and engagement in treatment for alcohol and other drug (AOD) abuse or dependence (equivalent to substance use disorder), as well as follow-up after an emergency department visit for AOD abuse or dependence. Another area proposed for broader adoption is universal screening for unhealthy alcohol use. Despite adoption of these five measures by health systems, the generalizability of these alcohol-related quality measures has not been fully established. This includes the lack of knowledge on the expected variability and reliability of quality measured at different levels of a health system (e.g., clinics, providers). In addition, limited information exists on the meaningful drivers of improved performance to guide health systems with quality improvement efforts. This study seeks to address these scientific evidence gaps through the following two specific aims: 1) examine the variability and reliability of care quality measures for unhealthy alcohol use, and 2) identify multi-level factors associated with care quality for unhealthy alcohol use. For each of the five quality measures of focus, hierarchical modeling will be applied to characterize the variability and reliability at four levels of health care delivery: patient, provider, clinic and community. Hypothesis generating analyses in Aim 2 will extend hierarchical models from Aim 1 and examine the influence of an expansive set of explanatory variables conceptually related to receipt of guideline concordant care. Research in all aims will be conducted within the Kaiser Permanente Washington (KPWA) Health System, which is part of one of the largest nonprofit healthcare systems in the US. KPWA is an ideal setting given its hierarchical structure and extensive administrative and electronic health record data to measure quality and multi-level determinants of care quality. Together, scientific insights gained from this study will provide best practices for the measurement of quality indicators and enhance reporting tools that disseminate quality information. This will support the study team's long-term goal of increasing the effectiveness of strategic performance reporting to accelerate efforts to improve care quality for unhealthy alcohol use. To achieve this goal, the study team will partner with KPWA delivery system leaders to develop prototype report cards informed by study findings that present the quality performance of providers and clinics in a manner that is easily interpretable and offer actionable insights.
项目摘要 不健康的饮酒仍然是一个严重的问题, 2001-2002年和2012-2013年。过度饮酒是可预防死亡的第三大原因, 慢性疾病、生产力损失和卫生系统的直接成本。基于证据的做法是 预防和治疗不健康的酒精使用及其有害后果。为促进吸收 这些做法,卫生系统使用质量措施,以确定各方面的护理正在做得很好,并监测 有待改进的领域。国家质量论坛已经批准了几项针对不健康的护理质量措施, 酒精使用,这已被卫生系统用于日常决策。其中包括指标 开始和参与酒精和其他药物(AOD)滥用或依赖治疗(相当于 物质使用障碍),以及对AOD滥用或 依赖建议更广泛采用的另一个领域是普遍筛查不健康的酒精使用。 尽管卫生系统采用了这五项措施,但这些与酒精相关的质量的普遍性 措施尚未完全确立。这包括缺乏对预期变异性的了解, 在卫生系统的不同级别测量的质量的可靠性(例如,诊所、供应商)。此外,有限 有关于改进绩效的有意义驱动因素的信息,以指导卫生系统的质量 改进的努力。本研究旨在通过以下两个方面来解决这些科学证据差距 具体目标:1)检查不健康酒精使用的护理质量措施的可变性和可靠性,以及2) 确定与不健康酒精使用的护理质量相关的多层次因素。五种品质的每一种 重点的措施,分层建模将被应用于表征的可变性和可靠性在四个级别 卫生保健服务提供:病人,提供者,诊所和社区。目标2中的假设生成分析将 从目标1扩展层次模型,并检查一组扩展的解释变量的影响 在概念上与接受指南一致性护理有关。所有目标的研究都将在 Kaiser Permanente华盛顿(KPWA)卫生系统,这是最大的非营利医疗保健之一的一部分, 系统在美国。KPWA是一个理想的设置,因为它的层次结构和广泛的行政和 电子健康记录数据,以衡量质量和护理质量的多层次决定因素。一起,科学 从这项研究中获得的见解将为质量指标的衡量提供最佳做法,并提高 传播高质量信息的报告工具。这将支持研究小组的长期目标, 提高战略业绩报告的有效性,以加快努力, 不健康的饮酒为了实现这一目标,研究团队将与KPWA交付系统领导者合作, 根据研究结果编制报告卡原型,介绍提供者的质量业绩, 以一种易于解释并提供可操作见解的方式为诊所提供服务。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Edwin Glass其他文献

Joseph Edwin Glass的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Edwin Glass', 18)}}的其他基金

C-DIAS RP3: Scaling-out app-based treatments: a multi-level strategy to promote equity across primary care patients with substance use
C-DIAS RP3:扩展基于应用程序的治疗:促进初级保健药物使用患者公平的多层次策略
  • 批准号:
    10493961
  • 财政年份:
    2022
  • 资助金额:
    $ 23.15万
  • 项目类别:
C-DIAS RP3: Scaling-out app-based treatments: a multi-level strategy to promote equity across primary care patients with substance use
C-DIAS RP3:扩展基于应用程序的治疗:促进初级保健药物使用患者公平的多层次策略
  • 批准号:
    10668496
  • 财政年份:
    2022
  • 资助金额:
    $ 23.15万
  • 项目类别:
Multi-level Influences of Alcohol Based Quality and Outcome Measures
酒精质量的多层次影响和结果测量
  • 批准号:
    10590820
  • 财政年份:
    2022
  • 资助金额:
    $ 23.15万
  • 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
  • 批准号:
    10092143
  • 财政年份:
    2019
  • 资助金额:
    $ 23.15万
  • 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
  • 批准号:
    10349443
  • 财政年份:
    2019
  • 资助金额:
    $ 23.15万
  • 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
  • 批准号:
    10560538
  • 财政年份:
    2019
  • 资助金额:
    $ 23.15万
  • 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字治疗:混合 III 型实施试验
  • 批准号:
    9902391
  • 财政年份:
    2019
  • 资助金额:
    $ 23.15万
  • 项目类别:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: Observational Analysis of Adaptions to the Intervention
初级保健中阿片类药物和其他物质使用障碍 (DIGITS) 的数字化治疗:干预措施适应的观察分析
  • 批准号:
    10652751
  • 财政年份:
    2019
  • 资助金额:
    $ 23.15万
  • 项目类别:
Decreasing the Engagement Gap for Addiction Treatment in Primary Care
缩小初级保健中成瘾治疗的参与差距
  • 批准号:
    9981556
  • 财政年份:
    2017
  • 资助金额:
    $ 23.15万
  • 项目类别:
Decreasing the Engagement Gap for Addiction Treatment in Primary Care
缩小初级保健中成瘾治疗的参与差距
  • 批准号:
    10222485
  • 财政年份:
    2017
  • 资助金额:
    $ 23.15万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 23.15万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 23.15万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.15万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.15万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 23.15万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.15万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.15万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 23.15万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.15万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.15万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了